StreetInsider.com News Articles

Form 4 SYNOPSYS INC For: Sep 15 Filed by: Ghazi Sassine

Wed, 16 Sep 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260916/27070379.html

Form 144 SYNOPSYS INC Filed by: Ghazi Sassine

Tue, 15 Sep 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260915/27064867.html

Form 4 SYNOPSYS INC For: Sep 11 Filed by: LEE JANET

Mon, 14 Sep 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260914/27058761.html

Wells Fargo Upgrades Synopsys (SNPS) to Overweight

Thu, 10 Sep 2026 05:12:28 -0400

Wells Fargo analyst Joe Quatrochi upgraded Synopsys (NASDAQ: SNPS) from Equal Weight to Overweight with a price target of $475.00 (from $450.00).

For an analyst ratings summary and ratings history on Synopsys click here. For more ratings news on Synopsys click here.

Shares of Synopsys closed at $393.22 yesterday.

Wells Fargo Upgrades Synopsys (SNPS) to Overweight

Thu, 10 Sep 2026 05:12:28 -0400

Wells Fargo analyst Joe Quatrochi upgraded Synopsys (NASDAQ: SNPS) from Equal Weight to Overweight with a price target of $475.00 (from $450.00).

For an analyst ratings summary and ratings history on Synopsys click here. For more ratings news on Synopsys click here.

Shares of Synopsys closed at $393.22 yesterday.

Morgan Stanley upgrades Synopsys as it turns selective on chip stocks

Tue, 08 Sep 2026 09:26:16 -0400

Investing.com -- Morgan Stanley has upgraded Synopsys to Overweight and turned more selective on European semiconductor stocks, citing widening valuation dispersion and signs that the memory cycle is nearing a late-cycle turn.

Analyst Lee Simpson said the firm remains positive on the sector overall. "We remain constructive on semis, underpinned by strong AI demand and a broadening cycle recovery," he wrote, though he added that with memory approaching an inflection, "we turn more selective."

On Synopsys, Simpson pointed to an attractive entry point after a recent de-rating, greater confidence in synergies from its Ansys acquisition and a recovery

Morgan Stanley upgrades Synopsys as it turns selective on chip stocks

Tue, 08 Sep 2026 09:26:16 -0400

On Synopsys, Simpson pointed to an attractive entry point after a recent de-rating, greater confidence in synergies from its Ansys acquisition and a recovery

Morgan Stanley Upgrades Synopsys (SNPS) to Overweight

Tue, 08 Sep 2026 03:37:56 -0400

Morgan Stanley analyst Lee Simpson upgraded Synopsys (NASDAQ: SNPS) from Equalweight to Overweight with a price target of $500.00.

The analyst comments: “Earlier this year we moved Synopsys to EW pending: (i) greater visibility on profitability from the integration of Ansys, (ii) a return to teens % growth in EDA and (iii) evidence that the co-design offering is as strategically important as competing platforms. We have since gained greater confidence in the synergy trajectory from the Ansys integration and in Design IP recovery. While we are yet to see a return to teens% EDA growth, we think the transition to physical

Morgan Stanley Upgrades Synopsys (SNPS) to Overweight

Tue, 08 Sep 2026 03:37:56 -0400

Morgan Stanley analyst Lee Simpson upgraded Synopsys (NASDAQ: SNPS) from Equalweight to Overweight with a price target of $500.00.

Form 144 SYNOPSYS INC Filed by: DE GEUS AART

Fri, 28 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260828/26998062.html

Form 144 SYNOPSYS INC Filed by: DE GEUS AART

Fri, 28 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260828/26998062.html

Synopsys upgrade bets on FY27 growth rebound and stronger chip-design demand

Thu, 27 Aug 2026 10:23:28 -0400

Investing.com -- Synopsys is positioned for a stronger fiscal 2027 as demand for electronic design automation and chip-design intellectual property improves, Baird said, upgrading the semiconductor software provider to Outperform and raising its price target to $560.

Baird said expectations have fallen sufficiently following a subdued fiscal 2026 that the risk-reward now favors the stock, particularly as recent results point to improving performance heading into fiscal 2027. The brokerage expects double-digit organic revenue growth next year and sees scope for revenue and free-cash-flow estimates to rise.

The company's third-quarter results provided an early indication of that recovery. Revenue rose 40% to about $2.48

Synopsys upgrade bets on FY27 growth rebound and stronger chip-design demand

Thu, 27 Aug 2026 10:23:28 -0400

The company's third-quarter results provided an early indication of that recovery. Revenue rose 40% to about $2.48

Benchmark Reiterates Buy Rating on Synopsys (SNPS) Following 2H Results

Thu, 27 Aug 2026 09:12:08 -0400

Benchmark analyst Gary Mobley reiterated a Buy rating and $570.00 price target on Synopsys (NASDAQ: SNPS).

The analyst commented, "Following upside to 2H FY26 results/guide, we reiterate our Buy rating and $570 price target. Given how low the bar was for SNPS shares (e.g., shares seemingly pricing in a negative revision to est, w/shares at 24.0x prior NTM EPS, lowest in years), we are surprised to see SNPS shares trading down in the aftermarket after what should be viewed as: 1) a clean beatand-raise; and 2) validation that AI is a tailwind to EDA/simulation software, not a headwind. Clearly, the company

Synopsys (SNPS) PT Lowered to $600 at JPMorgan

Thu, 27 Aug 2026 08:34:12 -0400

JPMorgan analyst Harlan Sur lowered the price target on Synopsys (NASDAQ: SNPS) to $600.00 (from $650.00) while maintaining a Overweight rating.

Synopsys (SNPS) PT Lowered to $550 at Mizuho

Thu, 27 Aug 2026 06:43:30 -0400

Mizuho analyst Siti Panigrahi lowered the price target on Synopsys (NASDAQ: SNPS) to $550.00 (from $600.00) while maintaining a Outperform rating.

Baird Upgrades Synopsys (SNPS) to Outperform

Thu, 27 Aug 2026 03:05:56 -0400

Baird analyst Jon Vruwink upgraded Synopsys (NASDAQ: SNPS) from Neutral to Outperform with a price target of $560.00 (from $558.00).

The analyst comments: “We upgrade our recommendation as FY27 can see the return to double-digit% organic revenue growth and upside to revenue/FCF estimates, and we would be surprised if this goes towards multiple compression (from low-20x P/E) instead of lifting the stock. We expect September 30 investor day will spotlight drivers of improvement across EDA software, Design IP, and Ansys, along with a good financial framework for FY27+. After upside in F3Q26 results and guidance (initial EDA acceleration in view), we

Baird Upgrades Synopsys (SNPS) to Outperform

Thu, 27 Aug 2026 03:05:56 -0400

Baird analyst Jon Vruwink upgraded Synopsys (NASDAQ: SNPS) from Neutral to Outperform with a price target of $560.00 (from $558.00).

Form 10-Q SYNOPSYS INC For: Jul 31

Wed, 26 Aug 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260826/26982716.html

Form 10-Q SYNOPSYS INC For: Jul 31

Wed, 26 Aug 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260826/26982716.html

Form 8-K/A SYNOPSYS INC For: Nov 09

Wed, 26 Aug 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260826/26982683.html

Form 8-K/A SYNOPSYS INC For: Nov 09

Wed, 26 Aug 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260826/26982683.html

Synopsys shares fall despite earnings beat and raised 2026 outlook

Wed, 26 Aug 2026 16:46:21 -0400

Investing.com --Synopsys shares fell in extended trading on Wednesday despite the chip-design software maker delivering third-quarter results above Wall Street expectations and raising its full-year outlook, as investors appeared to focus on the limited upside in its latest forecasts.

Despite the beats, the muted reaction suggests investors were looking for a stronger outlook relative to elevated expectations after Synopsys’ recent run of better-than-expected results. Shares had gained in the weeks leading into the report as optimism around the earnings release increased.

The company reported adjusted earnings of $3.91 per share, beating analysts’ estimate of $3.67, while revenue rose 42.4% year

After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX

Wed, 26 Aug 2026 16:35:51 -0400

After-Hours Movers:

NVIDIA (NASDAQ: NVDA)

NVIDIA traded choppily (last down 1%) despite topping Q2 estimates with an adjusted EPS of $2.22 on $96.2 billion in revenue, as high market expectations overshadowed the beat. The AI chip titan issued upbeat Q3 revenue guidance of $108.0 billion (±2%), though management explicitly noted that its outlook assumes zero Data Center compute revenue from China due to ongoing trade restrictions.

Synopsys (NASDAQ: SNPS)

Synopsys fell 6% following the release of its Q3 financial results. While the semiconductor design automation leader posted an EPS beat of $3.91 on $2.48 billion in revenue and raised its full-year guidance, profit-taking took

After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX

Wed, 26 Aug 2026 16:35:51 -0400

After-Hours Movers:

NVIDIA (NASDAQ: NVDA)

Synopsys (NASDAQ: SNPS)